Jeffrey Maxwell Holzbeierlein, M.D., F.A.C.S. - Publications

• Goetzl MA, Outman JE, Griebling TL, Holzbeierlein JM, Weigel JW, Thrasher JB: Digital Fecal Occult Blood Testing in the Ambulatory Urology Clinic. J Am Coll Surg 206(1):144-7, January 2008.
• Holzbeierlein JM: What Effect Does Androgen Suppression Therapy Have on Frequency and Timing of Fatal Myocardial Infarctions? Nat Clin Prac Oncol 5(2):74-5, February 2008.
• Karellas ME, Damjanov I, Holzbeierlein JM: ITGCN of the Testis, Contralateral Testicular Biopsy and Bilateral Testicular Cancer. Urol Clin North Am 34(2):119-25, May 2007.
• Tawfik OH, Kramer B, Shidleler B, Danley M, Kimler BF, Holzbeierlein JM: Prognostic Significance of CD44, Platelet-Derived Growth Factor Receptor Alpha, and Cyclooxygenase 2 Expression in Renal Cell Carcinoma. Arch Pathol Lab Med 131(2):267-7, February 2007.
• Vanveldhuizen PJ, Thrasher JB, Ray G, Cherian R, Ward J, Holzbeierlein JM, Gutow S, Banerjee SK: Dose Effect of Soy Supplementation in Prostate Cancer: A Pilot Study. Oncology Reports, 16(6):1221-1224 December 2006.
• Goetzl MA, Holzbeierlein JM: Finasteride as a Chemopreventative Agent in Prostate Cancer: Impact of the PCPT on Urologic Practice. Natl Clin Prac Urol 3(8):422-9, August 2006.
• Holzbeierlein JM: Managing Complications of Androgenic Deprivation Therapy for Prostate Cancer. Urol Clin North Am, 33(2):181-90 May 2006.
• Evangelidis A, Lee EK, Karellas ME, Thrasher JB, Holzbeierlein JM: Evaluation of Ureterointestinal Anastomosis: Wallace vs Bricker. J Urol 175(5):1755-1758; Discussion 1758, May 2006.
• Kramer BA, Gao X, Davis M, Hall M, Holzbeierlein JM, Tawfik O: Prognostic Significance of Ploidy, MIB-1 Proliferation Marker, and p53 in Renal Cell Carcinoma. J Am Coll Surg 201(4):565-70, October 2005.
• Yu XM, Shen G, Neckers L, Blake H, Holzbeierlein JM, Cronk B, Blagg BS: Hsp90 Inhibitors Identified from the Library of Novobiocin Analogues. J Am Chem Soc, 127(37):12778-9, September 2005.
• Holzbeierlein JM, McIntosh J, Thrasher JB: The Role of Soy Phytoestrogens in Prostate Cancer. Curr. Opin. Urol 15:17-22, 2005.
• Holzbeierlein JM, Langenstroer P, Porter HJ II, Thrasher JB: Case Selection and Outcome of Radical Perineal Prostatectomy in Localized Prostate Cancer. Int Braz J Urol 29(4):291-9, Jul-August 2003.
• Holzbeierlein JM, Porter HJ II, Thrasher JB: The Craft of Urologic Surgery: Modern Radical Perineal Prostatectomy. Urol.Clin. North Am 31(3):629-641, August 2004.
• Holzbeierlein JM, Lopez-Corona E, Bochner BH, Herr HW, Donat SM, Russo P, Dalbagni G, Sogani PC: Partical Cystectomy: A Contemporary Review of the Memorial Sloan-Kettering Cancer Center Expreience and Recommendations for Patient Selection. J Urol 172(3):878-81, September 2004.
• Holzberielein, JM: Payne R, Weigel J, Mardis H: Long-Term Followup of Metastatic Prostate Cancer. J Urol 171(6 Pt 1):2377. Kime 2004.
• Holzbeierlein, JM, McLaughlin MD, Thrasher JB: Complications of Androgen Deprivation Therapy. Curr. Opin. Urol 14(3):177-183, May 2004. Review.
• Holzbeierlein JM, Castle EP, Thrasher JB: Complications of Androgen-Deprivation Therapy: Prevention and Treatment. Oncology 18(3):303-9; discussion 310, 315, 319-21, March 2004. Review.
• Holzbeierlein JM, Castle EP, Thrasher JB: Complications of Androgen-Deprivation Therapy for Prostate Cancer. Clin. Prostate Cancer 2(3):147-52, Dec 2003. Review.
• Liao X, Thrasher JB, Holzbeierlein JM, Stanley S and Li B: Glycogen Synthase Kinase-3beta Activity is Required for Androgen-Stimulated Expression in Prostate Cancer. Endocrinology 145(6):2941-2949, 2004.
• Holzbeierlein JM, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, Reuter V, Gerald WL: Gene Expression Analysis of Human Prostate Carcinoma During Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance. AM J Pathol 164(1): 217-27, January 2004.
• Holzbeierlein JM, Sogani PC, Sheinfeld J: Histology and Clinical Outcomes in Patients with Bilateral Testicualr Germ Cell Tumors: the Memorial Sloan Kettering Center Experience 1950 to 2001. J Urol 169(6):2122-5, June 2003.
• Liao X, Thrasher JB, Pelling J, Holzbeierlein JM, Qing-Xiang AS and Li B: Androgen Stimulates Metalloproteinase Expression in Human Prostate Cancer. Endocrinology 144(5):1656-1663, May 2003.
• Holzbeierlein JM, Peterson M, Smith JA Jr: Variability of Results of Cavernous Nerve Stimulation during Radical Prostatectomy. J Urol 165(1):108-10, January 2001.
• Holzbeierlein JM, Pope JC IV, Adams MC, Bruner J, Tulipan N, Brock JW III: The Urodynamic Profile of Myelodysplasia in Childhood with Spinal Closure During Gestation. J Urol 164(4): 1336-9, October 2000.
• Grossklaus DJ, Holzbeierlein JM, Roth BJ, Smith JA Jr: Abnormal Mammogram as the Presenting Sign of Renal Cell Carcinoma. J Urol 163(4) 1239-40, April 2000.
• Holzbeierlein JM, Smith JA: Radical Prostatectomy and Collaborative Care Pathways. Semin Urol Oncol 18(1):60-5, October 2000.
• Holzbeierlein JM, Smith JA: Surgical Management of Noninvasive Bladder Cancer (stages Ta/T1/CIS). Urol Clin North Am 27(1):15-24, vii-viii, February 2000, Review.
• McNeil DH, Harris CH, Holzbeierlein JM, Shew RL, Traugh NE Jr, Papka RE: CGRP-Immunoreactive Primary Afferent Nerve Fibers in the Rat Urinary Bladder: Effects of Dorsal Rhizotomy and MK-801. Exp Neurol 118(3): 317-23, December 1992.
• McNeil DH, Shew RL, Holzbeierlein JM, Papka RE: Effects of Spinal Cord Transection and MK-801 on CGRP Immunostaining in the Rat Urinary Bladder. Exp Neurol 116(3): 339-44, June 1992.